News
The Hong Kong-listed firm is advancing its pipeline using an mRNA system it says can compete with the industry’s best.
Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...
10d
The Brighterside of News on MSNNew synthetic molecule targets and kills breast and pancreatic cancers in as few as three dosesScientists have developed a new molecule that can deliver powerful immune-activating treatment directly to cancer cells, ...
2d
The Brighterside of News on MSNBreakthrough mRNA vaccine shows 100% effectiveness against deadly bacteriaScientists at Tel Aviv University and the Israel Institute for Biological Research have developed the first mRNA vaccine proven completely effective against deadly bacteria. This groundbreaking ...
A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University ...
Welcome to our live blog tracking the latest news and developments from the United States. Stay updated with real-time ...
SHANGHAI, China I July 4, 2025 I Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing ...
BioNTech SE (NASDAQ: BNTX), and Bristol Myers Squibb (NYSE: BMY) have entered a global strategic partnership to co-develop ...
After Decades Without Progress in Glioblastoma, Diakonos Stirs up Interest in Dendritic Cell Vaccine
The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.
A new PanCAN-authored paper uses feedback provided by patients with pancreatic cancer to identify trends in reporting pain.
Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results